62 results
Page 2 of 4
8-K
EX-10.2
knja yy4j64hr
13 Oct 22
Invivyd Appoints Fred Driscoll as Interim Chief Financial Officer and Announces Resource Reallocation to Maximize Integrated Discovery
4:16pm
8-K
EX-10.1
9g3e2tanx5tfumijq hi
5 Jul 22
Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board of Directors
4:41pm
8-K
c4av7fsj9gz7erxn1pwj
22 Jun 22
Submission of Matters to a Vote of Security Holders
5:18pm
DEFC14C
pix2isb xnjrznvk
2 Jun 22
Information statement in contested solicitation
4:24pm
PRER14C
dd1soz2q1976kzo5tn
31 May 22
Preliminary revised information
5:09pm
PREC14C
ux43zeuzbvxu12
19 May 22
Preliminary information statement in contested solicitation
5:05pm
10-K/A
5u60s
29 Apr 22
Annual report (amended)
4:43pm
DEFC14A
i1owo80gv56tqgfh
29 Apr 22
Proxy in contested solicitation
4:02pm
PRRN14A
mhpg0dau12
27 Apr 22
Revised preliminary proxy statement filed by non-management
1:13pm
PREC14A
0r8y10d9gpu4
26 Apr 22
Preliminary proxy with contested solicitation
8:48am
PRRN14A
1387jgnoa
25 Apr 22
Revised preliminary proxy statement filed by non-management
5:23pm
PREC14A
4917eg1ho7unb
11 Apr 22
Preliminary proxy with contested solicitation
6:44am
10-K
EX-10.11
xxgsm4rq4b
31 Mar 22
Annual report
8:18am
10-K
0vtg6gp7 vqh5
31 Mar 22
Annual report
8:18am
8-K
EX-99.1
0vcfa63 cj
21 Mar 22
Departure of Directors or Certain Officers
6:32am
8-K/A
EX-99.1
tul 1zhcgxhl
21 Mar 22
Departure of Directors or Certain Officers
6:30am
8-K
9b97dti4
22 Nov 21
Adagio Therapeutics Announces Expansion of Management Team and Board of Directors
5:04pm
8-K
EX-99.1
sr07ju0 djr
22 Nov 21
Adagio Therapeutics Announces Expansion of Management Team and Board of Directors
5:04pm